Filtros : "Indexado no Chemical Abstracts" "Reino Unido" "Vaccine" Removidos: "WARD, RICHARD JOHN" "Emirados Árabes Unidos" Limpar

Filtros



Refine with date range


  • Source: Vaccine. Unidades: FM, FMVZ

    Subjects: HEPATITE, VACINAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SARTORI, Ana Marli Christovam et al. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context. Vaccine, v. 30, n. 52, p. 7489-7497, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2012.10.056. Acesso em: 30 set. 2024.
    • APA

      Sartori, A. M. C., Soárez, P. C. de, Novaes, H. M. D., Amaku, M., Azevedo, R. S. de, Moreira, R. C., et al. (2012). Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context. Vaccine, 30( 52), 7489-7497. doi:10.1016/j.vaccine.2012.10.056
    • NLM

      Sartori AMC, Soárez PC de, Novaes HMD, Amaku M, Azevedo RS de, Moreira RC, Pereira LMMB, Ximenes RA de A, Martelli CMT. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context [Internet]. Vaccine. 2012 ; 30( 52): 7489-7497.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.vaccine.2012.10.056
    • Vancouver

      Sartori AMC, Soárez PC de, Novaes HMD, Amaku M, Azevedo RS de, Moreira RC, Pereira LMMB, Ximenes RA de A, Martelli CMT. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context [Internet]. Vaccine. 2012 ; 30( 52): 7489-7497.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.vaccine.2012.10.056
  • Source: Vaccine. Unidade: FMRP

    Subjects: CÉLULAS DENDRÍTICAS, IMUNOTERAPIA, VACINAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SAENZ, Richard et al. HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen. Vaccine, v. 28, n. 47, p. 7556-7562, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2010.08.054. Acesso em: 30 set. 2024.
    • APA

      Saenz, R., Souza, C. da S., Huang, C. T., Larsson, M., Esener, S., & Messmer, D. (2010). HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen. Vaccine, 28( 47), 7556-7562. doi:10.1016/j.vaccine.2010.08.054
    • NLM

      Saenz R, Souza C da S, Huang CT, Larsson M, Esener S, Messmer D. HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen [Internet]. Vaccine. 2010 ; 28( 47): 7556-7562.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.vaccine.2010.08.054
    • Vancouver

      Saenz R, Souza C da S, Huang CT, Larsson M, Esener S, Messmer D. HMGB1-derived peptide acts as adjuvant inducing immune responses to peptide and protein antigen [Internet]. Vaccine. 2010 ; 28( 47): 7556-7562.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.vaccine.2010.08.054
  • Source: Vaccine. Unidade: FCF

    Subjects: PLASMODIUM, VACINAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BUENO, Lilian Lacerda et al. Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells. Vaccine, v. 27, n. 41, p. 5581-5588, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2009.07.031. Acesso em: 30 set. 2024.
    • APA

      Bueno, L. L., Morais, C. G., Soares, I. da S., Bouillet, L. E. M., Bruna-Romero, O., Fontes, C. J., et al. (2009). Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells. Vaccine, 27( 41), 5581-5588. doi:10.1016/j.vaccine.2009.07.031
    • NLM

      Bueno LL, Morais CG, Soares I da S, Bouillet LEM, Bruna-Romero O, Fontes CJ, Fujiwara RT, Braga ÉM. Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells [Internet]. Vaccine. 2009 ; 27( 41): 5581-5588.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.vaccine.2009.07.031
    • Vancouver

      Bueno LL, Morais CG, Soares I da S, Bouillet LEM, Bruna-Romero O, Fontes CJ, Fujiwara RT, Braga ÉM. Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells [Internet]. Vaccine. 2009 ; 27( 41): 5581-5588.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.vaccine.2009.07.031
  • Source: Vaccine. Unidades: FCF, IQ, ICB

    Subjects: ANTÍGENOS, ADJUVANTES IMUNOLÓGICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LINCOPAN, Nilton et al. Novel immunoadjuvants based on cationic lipid: preparation, characterization and activity in vivo. Vaccine, v. 27, n. 42, p. 5760-5771, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2009.07.066. Acesso em: 30 set. 2024.
    • APA

      Lincopan, N., Espíndola, N. M., Vaz, A. J., Costa, M. H. B. da, Faquim-Mauro, E., & Carmona-Ribeiro, A. M. (2009). Novel immunoadjuvants based on cationic lipid: preparation, characterization and activity in vivo. Vaccine, 27( 42), 5760-5771. doi:10.1016/j.vaccine.2009.07.066
    • NLM

      Lincopan N, Espíndola NM, Vaz AJ, Costa MHB da, Faquim-Mauro E, Carmona-Ribeiro AM. Novel immunoadjuvants based on cationic lipid: preparation, characterization and activity in vivo [Internet]. Vaccine. 2009 ; 27( 42): 5760-5771.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.vaccine.2009.07.066
    • Vancouver

      Lincopan N, Espíndola NM, Vaz AJ, Costa MHB da, Faquim-Mauro E, Carmona-Ribeiro AM. Novel immunoadjuvants based on cationic lipid: preparation, characterization and activity in vivo [Internet]. Vaccine. 2009 ; 27( 42): 5760-5771.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.vaccine.2009.07.066
  • Source: Vaccine. Unidade: EP

    Subjects: ANTÍGENOS DE VÍRUS, BIOQUÍMICA (PROCESSOS), CULTURA DE CÉLULAS ANIMAIS, IMUNOLOGIA, REATORES BIOQUÍMICOS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CONCEIÇÃO, Mateus Meneghesso et al. Viral antigen production in cell cultures on microcarriers:: bovine parainfluenza 3 virus and MDBK cells. Vaccine, v. 25, n. 45, p. 7785-7795, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2007.08.048. Acesso em: 30 set. 2024.
    • APA

      Conceição, M. M., Tonso, A., Freitas, C., & Pereira, C. A. (2007). Viral antigen production in cell cultures on microcarriers:: bovine parainfluenza 3 virus and MDBK cells. Vaccine, 25( 45), 7785-7795. doi:10.1016/j.vaccine.2007.08.048
    • NLM

      Conceição MM, Tonso A, Freitas C, Pereira CA. Viral antigen production in cell cultures on microcarriers:: bovine parainfluenza 3 virus and MDBK cells [Internet]. Vaccine. 2007 ; 25( 45): 7785-7795.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.vaccine.2007.08.048
    • Vancouver

      Conceição MM, Tonso A, Freitas C, Pereira CA. Viral antigen production in cell cultures on microcarriers:: bovine parainfluenza 3 virus and MDBK cells [Internet]. Vaccine. 2007 ; 25( 45): 7785-7795.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.vaccine.2007.08.048
  • Source: Vaccine. Unidade: FMRP

    Subjects: ADJUVANTES IMUNOLÓGICOS, VACINAS, TUBERCULOSE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIMA, Karla M. et al. Vaccine adjuvant: it makes the difference. Vaccine, v. 22, n. 19, p. 2374-2379, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2003.12.030. Acesso em: 30 set. 2024.
    • APA

      Lima, K. M., Santos, S. A. dos, Rodrigues, J. M., & Silva, C. L. (2004). Vaccine adjuvant: it makes the difference. Vaccine, 22( 19), 2374-2379. doi:10.1016/j.vaccine.2003.12.030
    • NLM

      Lima KM, Santos SA dos, Rodrigues JM, Silva CL. Vaccine adjuvant: it makes the difference [Internet]. Vaccine. 2004 ; 22( 19): 2374-2379.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.vaccine.2003.12.030
    • Vancouver

      Lima KM, Santos SA dos, Rodrigues JM, Silva CL. Vaccine adjuvant: it makes the difference [Internet]. Vaccine. 2004 ; 22( 19): 2374-2379.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.vaccine.2003.12.030
  • Source: Vaccine. Unidade: FMRP

    Subjects: RECÉM-NASCIDO, VACINAS VIRAIS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MOTTA, Márcia Soares Freitas da et al. Immunogenicity of Hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life. Vaccine, v. 20, p. 1557-1562, 2002Tradução . . Disponível em: https://doi.org/10.1016/s0264-410x(01)00493-5. Acesso em: 30 set. 2024.
    • APA

      Motta, M. S. F. da, Mussi-Pinhata, M. M., Jorge, S. M., Yoshida, C. F. T., & Souza, C. B. S. (2002). Immunogenicity of Hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life. Vaccine, 20, 1557-1562. doi:10.1016/s0264-410x(01)00493-5
    • NLM

      Motta MSF da, Mussi-Pinhata MM, Jorge SM, Yoshida CFT, Souza CBS. Immunogenicity of Hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life [Internet]. Vaccine. 2002 ; 20 1557-1562.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/s0264-410x(01)00493-5
    • Vancouver

      Motta MSF da, Mussi-Pinhata MM, Jorge SM, Yoshida CFT, Souza CBS. Immunogenicity of Hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life [Internet]. Vaccine. 2002 ; 20 1557-1562.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/s0264-410x(01)00493-5
  • Source: Vaccine. Unidades: FMRP, FCFRP

    Subjects: CITOCINAS, TUBERCULOSE, RATOS, IMUNOLOGIA, MICROBIOLOGIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIMA, Karla Melo et al. Comparison of different delivery systems of vaccination for the induction of protection against tuberculosis in mice. Vaccine, v. 19, p. 3518-3525, 2001Tradução . . Disponível em: https://doi.org/10.1016/s0264-410x(01)00042-1. Acesso em: 30 set. 2024.
    • APA

      Lima, K. M., Bonato, V. L. D., Faccioli, L. H., Brandão, I. T., Santos, S. A. dos, Coelho-Castelo, A. A. M., et al. (2001). Comparison of different delivery systems of vaccination for the induction of protection against tuberculosis in mice. Vaccine, 19, 3518-3525. doi:10.1016/s0264-410x(01)00042-1
    • NLM

      Lima KM, Bonato VLD, Faccioli LH, Brandão IT, Santos SA dos, Coelho-Castelo AAM, Leão SC, Silva CL. Comparison of different delivery systems of vaccination for the induction of protection against tuberculosis in mice [Internet]. Vaccine. 2001 ; 19 3518-3525.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/s0264-410x(01)00042-1
    • Vancouver

      Lima KM, Bonato VLD, Faccioli LH, Brandão IT, Santos SA dos, Coelho-Castelo AAM, Leão SC, Silva CL. Comparison of different delivery systems of vaccination for the induction of protection against tuberculosis in mice [Internet]. Vaccine. 2001 ; 19 3518-3525.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/s0264-410x(01)00042-1
  • Source: Vaccine. Unidade: FMRP

    Subjects: DOENÇAS INFECCIOSAS, EPIDEMIOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JIMENEZ, Raquel Ocazionez e FONSECA, Benedito Antonio Lopes da. Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice. Vaccine, v. 19, p. 648-654, 2001Tradução . . Disponível em: https://doi.org/10.1016/s0264-410x(00)00247-4. Acesso em: 30 set. 2024.
    • APA

      Jimenez, R. O., & Fonseca, B. A. L. da. (2001). Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice. Vaccine, 19, 648-654. doi:10.1016/s0264-410x(00)00247-4
    • NLM

      Jimenez RO, Fonseca BAL da. Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice [Internet]. Vaccine. 2001 ; 19 648-654.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/s0264-410x(00)00247-4
    • Vancouver

      Jimenez RO, Fonseca BAL da. Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice [Internet]. Vaccine. 2001 ; 19 648-654.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/s0264-410x(00)00247-4
  • Source: Vaccine. Unidade: FMRP

    Subjects: VACINAS VIRAIS, TUBERCULOSE, DNA, IMUNOTERAPIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LAWRIE, Douglas B. e SILVA, Célio Lopes. Enhancement of immunocompetence in tuberculosis by DNA vaccination. Vaccine, v. 18, n. 16, 2000Tradução . . Disponível em: https://doi.org/10.1016/s0264-410x(99)00512-5. Acesso em: 30 set. 2024.
    • APA

      Lawrie, D. B., & Silva, C. L. (2000). Enhancement of immunocompetence in tuberculosis by DNA vaccination. Vaccine, 18( 16). doi:10.1016/s0264-410x(99)00512-5
    • NLM

      Lawrie DB, Silva CL. Enhancement of immunocompetence in tuberculosis by DNA vaccination [Internet]. Vaccine. 2000 ; 18( 16):[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/s0264-410x(99)00512-5
    • Vancouver

      Lawrie DB, Silva CL. Enhancement of immunocompetence in tuberculosis by DNA vaccination [Internet]. Vaccine. 2000 ; 18( 16):[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/s0264-410x(99)00512-5

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024